<DOC>
	<DOC>NCT00971061</DOC>
	<brief_summary>The purpose of this study is to investigate the efficacy and safety of the Ahmed valve implant (AVI) and the Molteno single-plate implant (MSPI) in eyes with refractory glaucoma during a follow-up period of 24 months.</brief_summary>
	<brief_title>Ahmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<criteria>refractory glaucoma, defined as uncontrolled IOP despite maximal antiglaucoma medication, previously failed nonseton surgical treatment, or a combination thereof. age less than 40 years a visual acuity of no light perception lens opacity elevated IOP associated with silicone oil previous glaucoma drainage device implantation in the same eye previous cyclodestructive treatment increased risk of endophthalmitis posterior segment disorders preexisting ocular comorbidities.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Ahmed valve</keyword>
	<keyword>single-plate Molteno implant</keyword>
	<keyword>refractory glaucoma</keyword>
	<keyword>surgical treatment</keyword>
</DOC>